Medication management in long-term care can become complex quickly. Residents may be taking medications for several chronic conditions, receiving prescriptions from multiple providers, or returning to a facility with an updated regimen after a hospitalization or specialist visit.
In these situations, medication lists and clinical observations provide important context, but providers may sometimes need additional objective information. Toxicology testing can support medication monitoring by identifying certain drugs, metabolites, or other substances in a collected specimen.
For skilled nursing facilities and other long-term care organizations, the clinical value of toxicology testing depends on how appropriately it is ordered, interpreted, and incorporated into the resident's broader medication-management plan.
Long-term care populations frequently require ongoing management of multiple conditions. A resident may receive medications for pain, cardiovascular disease, behavioral health conditions, sleep disorders, or other chronic needs at the same time.
Medication regimens can also change as residents move between care settings. A hospital discharge, specialty consultation, emergency department visit, or change in clinical status may result in new prescriptions, discontinued medications, or revised dosing.
These transitions make accurate medication reconciliation especially important.
For organizations using long-term and supportive care laboratory solutions, diagnostic testing can become part of a broader strategy for maintaining consistent clinical information across routine care, transitions, and follow-up. PSC Dx specifically supports skilled nursing and long-term care organizations with laboratory testing and provider-focused diagnostic support.
Clinical toxicology testing provides laboratory information about substances present in a patient's specimen. Depending on the clinical situation and testing methodology, this may include prescribed medications, non-prescribed medications, or other substances.
In long-term care, providers may consider toxicology testing when laboratory information would help clarify a medication-related clinical question. Examples include evaluating whether findings are consistent with the documented medication plan, investigating an unexpected clinical presentation, or monitoring certain medications when testing is clinically appropriate.
Our toxicology testing services include drug screening, prescription medication monitoring, and advanced toxicology analysis, with urine, blood, and saliva among the available specimen types.
The important point is that laboratory testing should remain connected to a defined clinical purpose. Testing has the greatest value when the provider knows what question the result is intended to help answer.
Not every toxicology test provides the same level of information.
Presumptive screening is commonly used as an initial method for detecting selected classes of drugs or substances. It can provide useful information efficiently, but screening methods have analytical limitations. Depending on the assay, certain substances may not be detected, and some medications or compounds may contribute to unexpected findings.
Definitive testing provides greater analytical specificity and can identify individual drugs or metabolites when more precise information is clinically necessary.
The appropriate approach depends on the medication being evaluated, the reason for testing, the initial result, and how the information may affect clinical management.
This distinction is especially important when a result differs from what the care team expected. An unexpected screening result should prompt appropriate review rather than an immediate assumption about medication use.
A toxicology result represents one piece of a much larger clinical picture.
Providers should interpret findings alongside the resident's medication administration record, prescription history, recent medication changes, health status, and timing of specimen collection.
Several factors can influence what appears in a toxicology result. The timing of the last dose matters because drugs and metabolites remain detectable for different periods. Dose frequency, individual metabolism, kidney or liver function, specimen characteristics, and the sensitivity of the testing method may also affect findings.
Over-the-counter medications and other prescribed therapies should also be considered when interpreting an unexpected result.
For this reason, a result that appears inconsistent with the medication record often benefits from a structured review of the full clinical context and, when appropriate, additional laboratory clarification.
Medication management may involve more than one type of laboratory testing, but it is important to understand the clinical question each method addresses.
Toxicology testing evaluates drug or substance exposure in a specimen. Pharmacogenomic testing examines genetic variations that may influence how an individual responds to certain medications.
For residents experiencing medication-related challenges, these approaches may provide different types of information. Our Precision Rx pharmacogenomics testing is designed to provide genetic insights related to medication selection, dosing, and drug-gene interactions.
Keeping these purposes distinct helps providers select testing based on the clinical question rather than treating different medication-related tests as interchangeable.
For long-term care organizations, the testing method is only one part of an effective program. The surrounding workflow also matters.
Facilities benefit from defining when toxicology testing is clinically appropriate, who is responsible for placing orders, how specimens are collected and submitted, where results are delivered, and how unexpected findings are escalated for provider review.
Accurate medication documentation is particularly important. If a current prescription or recent medication change is missing from the record available to the interpreting provider, an otherwise explainable finding may appear unexpected.
Standardized collection and result-review procedures can also make the process easier for nursing staff and clinicians. The objective is to create a consistent pathway from the original clinical question through specimen collection, laboratory analysis, interpretation, and follow-up.
A laboratory supporting long-term care toxicology should be able to do more than process a specimen.
Providers should consider whether the laboratory offers appropriate toxicology capabilities, clear specimen requirements, dependable turnaround expectations, secure reporting, accessible support, and workflows that can scale across facilities.
We provide toxicology services that include flexible specimen options and confidential reporting, while its broader laboratory model is designed around provider workflows and multiple care environments.
The right laboratory relationship helps make diagnostic information easier to access and apply within established clinical processes.
Toxicology testing can provide valuable objective information when long-term care providers need additional insight into medication or substance exposure. Its greatest clinical value comes from appropriate test selection, careful interpretation, accurate medication documentation, and integration with the resident's complete clinical picture.
PSC Dx works with long-term care organizations and healthcare providers to deliver reliable toxicology testing and broader diagnostic support designed to fit existing clinical workflows.
Contact PSC Dx to discuss toxicology testing solutions for your long-term care facility or organization.
